Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-01-27 Purchase | 2023-02-02 3:04 pm | Nascent Biotech Inc. | NBIO | HOLDEN LOWELL THOMAS CFO | 20,000 | $0.14 | $2,800 | 10,418,277 (Indirect Direct) | View |
| 2023-01-27 Purchase | 2023-02-02 12:47 pm | Nascent Biotech Inc. | NBIO | HOLDEN LOWELL THOMAS CFO | 20,000 | $0.14 | $2,800 | 10,418,277 (Indirect Direct) | View |
| 2022-07-21 Sale | 2022-07-25 11:24 am | Nascent Biotech Inc. | NBIO | HOLDEN LOWELL THOMAS CFO | 5,000 | $0.26 | $1,300 | 10,132,277 (Indirect Direct) | View |
| 2019-12-30 Purchase | 2020-01-06 3:59 pm | Nascent Biotech Inc. | NBIO | HOLDEN LOWELL THOMAS CFO | 5,000 | $0.165 | $825 | 5,490,814 (Indirect Direct) | View |
| 2019-09-30 Purchase | 2019-10-07 07:52 am | Nascent Biotech Inc. | NBIO | HOLDEN LOWELL THOMAS CFO | 10,000 | $0.14 | $1,400 | 2,818,214 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-12-30 Other | 2023-01-03 3:09 pm | N/A N/A | Nascent Biotech Inc. | NBIO | Karas Douglas John Director | 25,000 | $0.2 | 1,511,482 (Direct) | View |
| 2022-12-30 Option Award | 2023-01-03 3:08 pm | N/A N/A | Nascent Biotech Inc. | NBIO | HOLDEN LOWELL THOMAS CFO | 231,000 | $0.2 | 10,398,277 (Direct) | View |
| 2022-12-30 Other | 2023-01-03 3:08 pm | N/A N/A | Nascent Biotech Inc. | NBIO | Carrick Sean President & CEO 10% Owner | 462,000 | $0.2 | 18,533,607 (Direct) | View |
| 2022-04-14 Gift | 2022-04-19 09:58 am | N/A N/A | Nascent Biotech Inc. | NBIO | HOLDEN LOWELL THOMAS CFO | 700,000 | $0.08 | 8,283,077 (Direct) | View |
| 2022-03-09 Other | 2022-04-04 4:01 pm | N/A N/A | Nascent Biotech Inc. | NBIO | Karas Douglas John Director | 300,000 | $0.05 | 1,727,853 (Direct) | View |
| 2022-03-09 Other | 2022-04-04 4:01 pm | N/A N/A | Nascent Biotech Inc. | NBIO | HOLDEN LOWELL THOMAS CFO | 1,100,000 | $0.05 | 12,298,077 (Direct) | View |
| 2022-03-09 Other | 2022-04-04 4:01 pm | N/A N/A | Nascent Biotech Inc. | NBIO | HOLDEN LOWELL THOMAS CFO | 215,000 | $0.056 | 12,298,077 (Direct) | View |
| 2022-03-09 Other | 2022-04-04 4:01 pm | N/A N/A | Nascent Biotech Inc. | NBIO | Carrick Sean President & CEO 10% Owner | 1,000,000 | $0.05 | 18,881,131 (Direct) | View |
| 2022-03-09 Other | 2022-04-04 4:01 pm | N/A N/A | Nascent Biotech Inc. | NBIO | Carrick Sean President & CEO 10% Owner | 430,000 | $0.056 | 18,881,131 (Direct) | View |
| 2021-04-15 Other | 2022-02-08 5:07 pm | N/A N/A | Nascent Biotech Inc. | NBIO | HOLDEN LOWELL THOMAS CFO | 173,700 | $0.105 | 10,715,477 (Direct) | View |
| 2021-04-15 Gift | 2022-02-08 5:07 pm | N/A N/A | Nascent Biotech Inc. | NBIO | HOLDEN LOWELL THOMAS CFO | 3,400,000 | $0.05 | 10,715,477 (Direct) | View |
| 2021-06-30 Other | 2022-02-08 5:06 pm | N/A N/A | Nascent Biotech Inc. | NBIO | Carrick Sean President & CEO 10% Owner | 347,400 | $0.105 | 16,368,531 (Direct) | View |
| 2021-06-30 Other | 2021-08-20 09:50 am | N/A N/A | Nascent Biotech Inc. | NBIO | HOLDEN LOWELL THOMAS CFO | 700,000 | $0.105 | 18,383,554 (Indirect) | View |
| 2021-06-30 Other | 2021-08-20 09:50 am | N/A N/A | Nascent Biotech Inc. | NBIO | HOLDEN LOWELL THOMAS CFO | 173,700 | $0.061 | 18,383,554 (Direct) | View |
| 2021-06-30 Other | 2021-08-20 09:49 am | N/A N/A | Nascent Biotech Inc. | NBIO | Carrick Sean President & CEO 10% Owner | 347,400 | $0.105 | 16,368,531 (Direct) | View |
| 2021-04-09 Other | 2021-08-20 09:48 am | N/A N/A | Nascent Biotech Inc. | NBIO | Karas Douglas John Director | 307,010 | $0.076 | 1,518,198 (Direct) | View |
| 2021-04-09 Other | 2021-08-20 09:48 am | N/A N/A | Nascent Biotech Inc. | NBIO | Karas Douglas John Director | 83,334 | $0.105 | 1,518,198 (Direct) | View |
| 2021-03-31 Other | 2021-04-06 12:32 pm | N/A N/A | Nascent Biotech Inc. | NBIO | Karas Douglas John Director | 83,334 | $0.07 | 856,558 (Direct) | View |
| 2021-03-26 Other | 2021-04-06 12:31 pm | N/A N/A | Nascent Biotech Inc. | NBIO | Carrick Sean President & CEO 10% Owner | 1,250,000 | $0.06 | 18,543,731 (Direct) | View |
| 2021-03-26 Other | 2021-04-06 12:31 pm | N/A N/A | Nascent Biotech Inc. | NBIO | Carrick Sean President & CEO 10% Owner | 1,620,000 | $0.061 | 18,543,731 (Direct) | View |
| 2021-03-26 Other | 2021-04-06 12:28 pm | N/A N/A | Nascent Biotech Inc. | NBIO | HOLDEN LOWELL THOMAS CFO | 1,000,000 | $0.06 | 12,178,077 (Direct) | View |
| 2021-03-26 Other | 2021-04-06 12:28 pm | N/A N/A | Nascent Biotech Inc. | NBIO | HOLDEN LOWELL THOMAS CFO | 810,000 | $0.061 | 12,178,077 (Direct) | View |
| 2020-09-30 Other | 2021-01-11 5:00 pm | N/A N/A | Nascent Biotech Inc. | NBIO | Karas Douglas John Director | 108,460 | $0.046 | 1,219,780 (Direct) | View |
| 2020-09-30 Other | 2021-01-11 5:00 pm | N/A N/A | Nascent Biotech Inc. | NBIO | Karas Douglas John Director | 71,430 | $0.07 | 1,219,780 (Direct) | View |
| 2020-09-30 Other | 2021-01-11 5:00 pm | N/A N/A | Nascent Biotech Inc. | NBIO | Karas Douglas John Director | 350,000 | $0.05 | 1,219,780 (Direct) | View |
| 2020-09-30 Other | 2021-01-11 5:00 pm | N/A N/A | Nascent Biotech Inc. | NBIO | HOLDEN LOWELL THOMAS CFO | 127,970 | $0.07 | 10,128,047 (Direct) | View |
| 2020-09-30 Other | 2021-01-11 5:00 pm | N/A N/A | Nascent Biotech Inc. | NBIO | HOLDEN LOWELL THOMAS CFO | 1,442,000 | $0.0461 | 10,128,047 (Direct) | View |
| 2020-09-30 Other | 2021-01-11 5:00 pm | N/A N/A | Nascent Biotech Inc. | NBIO | Carrick Sean President & CEO 10% Owner | 218,715 | $0.1 | 15,906,446 (Direct) | View |
| 2020-09-30 Other | 2021-01-11 5:00 pm | N/A N/A | Nascent Biotech Inc. | NBIO | Carrick Sean President & CEO 10% Owner | 2,884,000 | $0.0461 | 15,906,446 (Direct) | View |
| 2020-06-24 Other | 2020-07-02 1:36 pm | N/A N/A | Nascent Biotech Inc. | NBIO | Price Brandon Senior VP Business Development 10% Owner | 3,355,830 | $0.1 | 10,358,158 (Direct) | View |
| 2020-06-24 Other | 2020-07-02 1:34 pm | N/A N/A | Nascent Biotech Inc. | NBIO | HOLDEN LOWELL THOMAS CFO | 3,435,890 | $0.1 | 10,423,997 (Direct) | View |
| 2020-06-24 Other | 2020-07-02 1:33 pm | N/A N/A | Nascent Biotech Inc. | NBIO | Carrick Sean President & CEO 10% Owner | 7,044,000 | $0.1 | 16,745,016 (Direct) | View |
| 2020-05-11 Other | 2020-05-13 11:10 am | N/A N/A | Nascent Biotech Inc. | NBIO | HOLDEN LOWELL THOMAS CFO | 1,000,000 | $0.1 | 4,562,217 (Direct) | View |
| 2020-03-27 Other | 2020-04-03 06:02 am | N/A N/A | Nascent Biotech Inc. | NBIO | Carrick Sean President & CEO | 441,930 | $0.13 | 3,098,946 (Direct) | View |
| 2020-03-27 Other | 2020-04-03 06:02 am | N/A N/A | Nascent Biotech Inc. | NBIO | HOLDEN LOWELL THOMAS CFO | 265,160 | $0.13 | 3,112,537 (Direct) | View |
| 2020-03-27 Other | 2020-04-03 06:02 am | N/A N/A | Nascent Biotech Inc. | NBIO | Price Brandon Exec VP Business Development | 265,160 | $0.13 | 2,959,277 (Direct) | View |
| 2019-12-30 Other | 2020-01-06 3:59 pm | N/A N/A | Nascent Biotech Inc. | NBIO | HOLDEN LOWELL THOMAS CFO | 886,700 | $0.1 | 5,490,814 (Direct) | View |
| 2019-12-30 Other | 2020-01-06 3:58 pm | N/A N/A | Nascent Biotech Inc. | NBIO | Price Brandon Senior VP Business Development 10% Owner | 756,700 | $0.1 | 3,185,657 (Direct) | View |
| 2019-12-30 Other | 2020-01-06 3:58 pm | N/A N/A | Nascent Biotech Inc. | NBIO | Glassy Mark 10% Owner | 90,000 | $0.1 | 4,366,500 (Direct) | View |
| 2019-12-30 Other | 2020-01-06 3:57 pm | N/A N/A | Nascent Biotech Inc. | NBIO | Carrick Sean President & CEO 10% Owner | 304,500 | $0.1 | 2,519,586 (Direct) | View |
| 2019-09-30 Other | 2019-10-07 07:56 am | N/A N/A | Nascent Biotech Inc. | NBIO | Price Brandon Senior VP Business Development 10% Owner | 7,500 | $0.126 | 1,679,757 (Direct) | View |
| 2019-09-30 Other | 2019-10-07 07:52 am | N/A N/A | Nascent Biotech Inc. | NBIO | HOLDEN LOWELL THOMAS CFO | 7,500 | $0.128 | 2,818,214 (Direct) | View |
| 2019-09-30 Other | 2019-10-07 07:50 am | N/A N/A | Nascent Biotech Inc. | NBIO | Carrick Sean President & CEO 10% Owner | 12,500 | $0.126 | 1,923,086 (Direct) | View |
| 2019-06-25 Other | 2019-07-08 11:56 am | N/A N/A | Nascent Biotech Inc. | NBIO | HOLDEN LOWELL THOMAS CFO | 23,965 | $0.186 | 1,416,822 (Direct) | View |
| 2019-06-25 Other | 2019-07-08 11:54 am | N/A N/A | Nascent Biotech Inc. | NBIO | Carrick Sean President & CEO 10% Owner | 39,942 | $0.186 | 1,938,028 (Direct) | View |
| 2019-06-25 Other | 2019-07-08 11:52 am | N/A N/A | Nascent Biotech Inc. | NBIO | Karas Douglas John Director | 50,000 | $0.186 | 160,000 (Direct) | View |
| 2019-06-25 Other | 2019-07-08 11:51 am | N/A N/A | Nascent Biotech Inc. | NBIO | Price Brandon Senior VP Business Development 10% Owner | 23,965 | $0.186 | 1,688,722 (Direct) | View |
| 2019-06-04 Option Award | 2019-06-06 09:20 am | N/A N/A | Nascent Biotech Inc. | NBIO | Price Brandon Senior VP Business Development 10% Owner | 368,218 | $0.154 | 1,640,792 (Direct) | View |